董事会薪酬与考核委员会关于 2025 年限制性股票激励计划 预留授予激励对象名单的核查意见（预留授予日） 汇绿生态科技集团股份有限公司 （4）具有《公司法》规定的不得担任公司董事、高级管理人员情形的； （5）法律法规规定不得参与上市公司股权激励的； （6）中国证监会认定的其他情形。 计持有公司 5%以上股份的股东或实际控制人及其配偶、父母、子女。 预留授予的激励对象均未发生不得授予限制性股票的情形。 资助的计划或安排。 汇绿生态科技集团股份有限公司（以下简称"公司"）董事会薪酬与考核委 员会依据《中华人民共和国公司法》（简称《公司法》）、《上市公司股权激励 管理办法》（以下简称"《管理办法》"）等有关法律、法规及规范性文件和《公 司章程》的规定，对公司《2025 年限制性股票激励计划（草案）》（以下简称 "本激励计划"）预留授予激励对象名单（预留授予日）进行了核查，并发表核 查意见如下： 成为激励对象的情形： （1）最近 12 个月内被证券交易所认定为不适当人选； （2）最近 12 个月内被中国证监会及其派出机构认定为不适当人选； （3）最近 12 个月内因重大违法违规行为被中国证监会及其派出机构行政处 罚或 ...

证券代码：001267 证券简称：汇绿生态 公告编号：2025-086 汇绿生态科技集团股份有限公司 关于向 2025 年限制性股票激励计划激励对象 本公司及董事会全体成员保证信息披露的内容真实、准确和完整，没有虚假记 载、误导性陈述或重大遗漏。 重要内容提示： 汇绿生态科技集团股份有限公司（以下简称"公司"）于 2025 年 9 月 4 日召开 了第十一届董事会第十二次会议及第十一届董事会薪酬与考核委员会第四次会议， 审议通过了《关于向 2025 年限制性股票激励计划激励对象授予预留限制性股票的 《汇绿生态科技集团股份有限公司 2025 议案》，根据《上市公司股权激励管理办法》 年限制性股票激励计划（草案）》的相关规定及公司 2025 年第二次临时股东会的 授权，董事会认为公司 2025 年限制性股票激励计划（以下简称"本激励计划"） 预留授予限制性股票的授予条件已经满足，同意以 2025 年 9 月 4 日为授予日，向 符合授予条件的 8 名激励对象授予合计 100 万股限制性股票，授予价格为 4.55 元/ 股。现将有关事项公告如下： 一、股权激励计划简述及已履行的相关审批程序 （一）本次股权激励计划简 ...

Core Viewpoint - The legal opinion letter confirms that the 2025 restricted stock incentive plan of Huigreen Ecological Technology Group Co., Ltd. has obtained the necessary approvals and complies with relevant laws and regulations [1][12]. Group 1: Approval and Authorization of the Grant - The company has passed resolutions regarding the 2025 restricted stock incentive plan, including the draft and implementation assessment management measures, and has authorized the board of directors to handle related matters [3][4][5]. - The independent directors have provided independent opinions on the incentive plan, and the supervisory board has conducted a review and issued opinions on the plan [3][4]. Group 2: Adjustment of Grant Price - The board of directors has approved the adjustment of the grant price for the reserved portion of the restricted stock to RMB 4.55 per share, following the company's dividend distribution [6][10]. - The adjustment method for the grant price is based on the dividend amount per share, ensuring compliance with the management regulations [7][10]. Group 3: Grant Date and Conditions - The grant date for the reserved portion of the restricted stock is set for September 4, 2025, as authorized by the shareholders' meeting [9][12]. - The conditions for granting the restricted stock include the absence of adverse audit reports and the eligibility of the incentive objects, which have been verified by the company's legal counsel [9][12]. Group 4: Disclosure of Information - The company is required to disclose relevant documents related to the grant in accordance with the management regulations and will fulfill its ongoing disclosure obligations [11][12].

Core Viewpoint - The announcement details the upcoming listing and circulation of 1,500,000 shares from the strategic placement of Suzhou Shengke Communication Co., Ltd., which will be available for trading starting September 15, 2025, after a 24-month lock-up period [1][2]. Group 1: Listing Details - The total number of shares to be listed is 1,500,000, representing 0.37% of the company's total share capital [2][5]. - The shares are part of the strategic placement from the company's initial public offering (IPO) and will be released for trading after the expiration of the lock-up period [2][4]. - The listing date is set for September 15, 2025, due to September 14 being a non-trading day [1][4]. Group 2: Shareholder Information - The sole shareholder of the restricted shares is China International Capital Corporation's wholly-owned subsidiary, China CICC Wealth Securities Co., Ltd. [2]. - The lock-up period for these shares began on the date of the company's IPO and will last for 24 months [2][3]. Group 3: Compliance and Verification - The underwriting institution has confirmed that the shareholder has adhered to all commitments made during the IPO process [3]. - The company has not experienced any changes in share capital due to profit distribution or other factors since the formation of the restricted shares [2][3].

Core Viewpoint - The company has adjusted the reserved grant price for the 2025 restricted stock incentive plan from 4.60 CNY per share to 4.55 CNY per share, following the necessary approvals and in accordance with relevant regulations [1][4][5]. Summary by Sections Approval Process - The company held the 12th meeting of the 11th Board of Directors and the 4th meeting of the Compensation and Assessment Committee on September 4, 2025, where the adjustment of the reserved grant price was approved [1][2]. - The necessary legal opinions were provided by Hubei Chuangzhi Law Firm, and the Supervisory Board also reviewed and approved the relevant proposals [2][3]. Adjustment Details - The adjustment of the reserved grant price was made to ensure fairness and reasonableness, aligning it with the initial grant price [4]. - The adjustment was calculated based on a dividend distribution of 0.05 CNY per share, leading to the new grant price of 4.55 CNY per share [5]. Impact on the Company - The adjustment is in compliance with the relevant laws and regulations and will not have a substantial impact on the company's financial status or operational results [5][6]. - The Compensation and Assessment Committee confirmed that the adjustment aligns with the company's incentive plan and does not harm the interests of the company or its shareholders [5][6]. Legal Opinions - The legal opinion concluded that the necessary approvals for the adjustment have been obtained and that the adjustment complies with the applicable laws and regulations [6].

Key Points - The convertible bond "Jin Neng Convertible Bond" will mature on October 13, 2025, with a total redemption amount of 110 RMB per bond, including tax and the last interest payment [1][2][3] - The redemption funds will be distributed on October 14, 2025, and the last trading day for the convertible bond will be September 30, 2025 [1][3] - Holders of the convertible bond can convert their bonds into company shares from October 9 to October 13, 2025, at a conversion price of 7.62 RMB per share [3] - The bond was issued on October 18, 2019, with a total fundraising amount of 1.5 billion RMB, netting approximately 1.486 billion RMB after deducting issuance costs [2]

Group 1 - The company has changed its name to "Jinyu Jidong Cement Group Co., Ltd." and its securities abbreviation to "Jinyu Jidong" [1][2] - The company has completed the industrial and commercial change registration and obtained a new business license from the Tangshan Administrative Approval Bureau [2] - The name change does not affect the names, abbreviations, or codes of the already issued bonds, and the legal effectiveness of existing legal documents related to the bonds remains unchanged [2] Group 2 - The company has expanded its operations over 30 years to cover 13 provinces in China and has also extended its business to northern South Africa [1] - The shareholding structure has changed significantly, with Beijing Jinyu Group Co., Ltd. directly holding 44.34% and indirectly holding 17.22% of the company's shares [1] - The name change is expected to reduce external communication costs and enhance the brand value of "Jinyu" and "Jidong," benefiting the company and all shareholders [1]

Summary of Key Points Core Viewpoint - The company has successfully completed a share buyback program, acquiring 20,945,992 shares, which represents 1.05% of its total share capital, with a total expenditure of 222.20 million yuan [1][3]. Group 1: Buyback Plan Details - The buyback plan was first disclosed on May 14, 2025, proposed by the company's director and general manager, Hu Danfeng [1]. - The implementation period for the buyback is from May 13, 2025, to May 12, 2026 [1]. - The expected buyback amount ranges from 200 million yuan to 300 million yuan, with a maximum buyback price set at 15.95 yuan per share [2][3]. Group 2: Execution of Buyback - The company executed its first share buyback on July 14, 2025, through a centralized bidding transaction [2]. - The actual buyback price ranged from 9.96 yuan to 11 yuan per share, with an average price of 10.61 yuan per share [3]. - The execution of the buyback plan aligns with the originally disclosed plan, and it will not significantly impact the company's operations, finances, or future development [3]. Group 3: Shareholder Impact - The buyback shares will be used for employee stock ownership plans or equity incentives, and any unutilized shares within the legal timeframe will be canceled [4]. - Before the buyback, the total number of shares was 1,990,650,596, which increased to 1,996,475,866 after the buyback [4]. - The company’s major stakeholders, including directors and controlling shareholders, did not trade the company's stock during the buyback announcement period [3].

Overview - Xiamen Kingdomway Group Co., Ltd. is issuing convertible bonds totaling RMB 1,292.39 million (12,923,948 bonds) [4][19] - The bonds will be listed on the Shenzhen Stock Exchange on September 8, 2025 [4][8] - The bonds have a maturity period from August 20, 2025, to August 19, 2031 [4][19] Company Information - The company was established on November 24, 1997, and is primarily engaged in the research, production, and sales of nutritional health foods and feed additives [11][12] - The registered capital of the company is RMB 609.93 million [9] - The company operates under the stock code 002626 and is listed on the Shenzhen Stock Exchange since October 28, 2011 [9][10] Business Operations - The main products include Coenzyme Q10, DHA, ARA, and various vitamins, with Coenzyme Q10 being the primary raw material [11] - The company has two major brands in the health food sector: Doctor's Best and Zipfizz [11] - The production model includes both self-production and contract manufacturing, with a focus on meeting customer demand [12] Financial Information - The total amount of the convertible bonds issued is RMB 1,292.39 million, with each bond having a face value of RMB 100 [19][20] - The interest rates for the bonds will increase progressively from 0.10% in the first year to 2.00% in the sixth year [20] - The net proceeds from the bond issuance will be used for various projects, including the construction of production facilities for Coenzyme Q10 and other operational needs [19][20] Shareholding Structure - The controlling shareholder is Xiamen Kingdomway Investment Co., Ltd., holding 34.71% of the company's shares [14][15] - The top ten shareholders include both domestic and foreign entities, with significant stakes held by state-owned enterprises [14][15] Credit Rating - The bonds have been rated AA by Dongfang Jincheng International Credit Rating Co., Ltd., with a stable outlook [6][20] - The bonds are not secured by any collateral [6][20]

Core Viewpoint - The company announces the mandatory redemption of its convertible bonds ("Mingdian Convertible Bonds") on September 8, 2025, at a price of 101.83 yuan per bond, urging investors to convert their bonds into shares before the deadline to avoid potential losses [1][2][3] Group 1: Redemption Details - The "Mingdian Convertible Bonds" will stop conversion after the market closes on September 5, 2025, with only one trading day left before the redemption date [1][2] - The redemption price is set at 101.83 yuan per bond, which includes accrued interest calculated based on a 2.5% annual interest rate [10][12] - The company has triggered the conditional redemption clause as the stock price met the required threshold for at least 15 trading days within a 30-day period [2][10] Group 2: Bond Issuance and Market Performance - The company issued 67.3 million convertible bonds with a face value of 100 yuan each, totaling 6.73 billion yuan, which were listed on the Shenzhen Stock Exchange on January 5, 2021 [3][4] - The initial conversion price was set at 24.23 yuan per share, later adjusted down to 11.89 yuan per share as of May 30, 2024, due to various factors including profit distribution [4][7][9] Group 3: Investor Guidance - Investors are advised to pay attention to the risks associated with the inability to convert their bonds if they are under pledge or freeze [2][3] - The company emphasizes the importance of timely conversion to avoid losses, given the significant difference between the market price and the redemption price [2][10]